SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-365547
Filing Date
2015-11-04
Accepted
2015-11-04 11:55:39
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d97530d10q.htm 10-Q 351198
2 EX-10.1 d97530dex101.htm EX-10.1 76075
3 EX-31.1 d97530dex311.htm EX-31.1 8447
4 EX-31.2 d97530dex312.htm EX-31.2 8781
5 EX-32.1 d97530dex321.htm EX-32.1 4430
  Complete submission text file 0001193125-15-365547.txt   3463367

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20150930.xml EX-101.INS 610986
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20150930.xsd EX-101.SCH 46754
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20150930_cal.xml EX-101.CAL 86647
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20150930_def.xml EX-101.DEF 119789
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20150930_lab.xml EX-101.LAB 342521
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20150930_pre.xml EX-101.PRE 253002
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 151196060
SIC: 2835 In Vitro & In Vivo Diagnostic Substances